Mindoperone

This classification denotes an anxiolytic with the molecular formula C25H29FN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 556OP2G5M2, chemically known as butyrophenone, 4-fluoro-4-(4-(6-methoxy-2-methylindol-3-yl)piperidino)- but generally known as mindoperone, which bears US NIH Compound Identifier 172296. European Medicines Agency schedules Mindoperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08977MIG. The term MINDOPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). MINDOPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mindoperone under HS 29333999 and SITC 51574. As of Q4 2014, MINDOPERONE remains the US FDA Preferred Term for this commodity. Mindoperone bears US NLM identifiers UMLS ID C1881853 and NCI Concept Code C66160. SMILES: FC1CCC(C(=O)CCCN2CCC(CC2)C2C3C([NH]C2C)CC(OC)CC3)CC1.